EUVIMEDEUVIMED entdecken
Open Access

Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice

Tuancheng Feng, Huan Du, Cha Yang, Ya Wang, Fenghua Hu iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02702-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Tuancheng Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, …. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Frontotemporal Lobar Degeneration, Membrane Proteins, Nerve Tissue Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TMEM106B, a gene encoding a lysosome membrane protein, is tightly associated with brain aging, hypomyelinating leukodystrophy, and multiple neurodegenerative diseases, including frontotemporal lobar degeneration with TDP-43 aggregates (FTLD-TDP). Recently, TMEM106B polymorphisms have been associated with tauopathy in chronic traumatic encephalopathy (CTE) and FTLD-TDP patients. However, how TMEM106B influences Tau pathology and its associated neurodegeneration, is unclear. Here we show that loss of TMEM106B enhances the accumulation of pathological Tau, especially in the neuronal soma in the hippocampus, resulting in severe neuronal loss in the PS19 Tau transgenic mice. Moreover, Tmem106b-/- PS19 mice develop significantly increased abnormalities in the neuronal cytoskeleton, autophagy-lysosome activities, as well as glial activation, compared with PS19 and Tmem106b-/- mice. Together, our findings demonstrate that loss of TMEM106B drastically exacerbates Tau pathology and its associated disease phenotypes, and provide new insights into the roles of TMEM106B in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaFrontotemporal Lobar DegenerationMembrane ProteinsNerve Tissue ProteinsAnimalsHumansMiceMice, Transgenictau Proteins

Stichwörter der Autor:innen

LysosomeNeurodegenerationPS19TMEM106BTau

Substanzen

Membrane ProteinsNerve Tissue Proteinstau ProteinsTMEM106B protein, humanTmem106b protein, mouse

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA.
  • Department of Molecular Biology and Genetics, Weill Institute for Cell and Molecular Biology, Cornell University, 345 Weill Hall, Ithaca, NY, 14853, USA. fh87@cornell.edu.

ORCID-Profile: Fenghua Hu

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Feng, T., Du, H., Yang, C., Wang, Y., & Hu, F. (2024). Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02702-4

Vancouver

Feng T, Du H, Yang C, Wang Y, Hu F. Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02702-4

BibTeX
@article{Feng2024,
  author = {Feng, Tuancheng and Du, Huan and Yang, Cha and Wang, Ya and Hu, Fenghua},
  title = {Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02702-4}
}
Kostenlos starten →